Product Theaters
Skip to Content

Sunday, June 2

9:15 AM - 9:45 AM | Product Theater A | AstraZeneca

The Evolving Intersection of Monoclonal Antibodies and Infectious Diseases

This AstraZeneca-sponsored program “The Evolving Intersection of Monoclonal Antibodies and Infectious Diseases” will provide attendees with a review of the immune response to infection and the mechanisms in which vaccines and monoclonal antibodies can help prevent infectious disease in immunocompromised hosts.


  • Catia Ferreira, PhD

9:15 AM - 9:45 AM | Product Theater B | Thermo Fisher Scientific

New Immunologic Risk Assessment Paradigms

This session will provide an overview of novel biomarkers offered by Thermo Fisher Scientific’s One Lambda Laboratories to support immunologic risk assessment. The One Lambda Pre-Transplant Risk Assay is an emerging laboratory-developed test that leverages data from 10 genes shown to provide information about early acute rejection risk. The One Lambda CXCL10 Assay, which detects the inflammatory biomarker CXCL10 in patient urine samples, will also be featured.


  • Stuart Knechtle, MD
  • Josh Augustine, MD

2:30 PM - 3:00 PM | Product Theater A | Alnylam Pharmaceuticals

PH1 Diagnosis and Management: A Dual Case Study Exploration

This symposium delves into the challenging world of Primary Hyperoxaluria Type 1 (PH1), presenting an analysis of two case studies that shed light on their path to diagnosis. PH1, a rare genetic disorder characterized by excessive oxalate production leading to kidney stones and renal failure which can pose significant diagnosis and management challenges. Our session aims to unravel the complexities of PH1 through the lens of these case studies, each illustrating diagnostic dilemmas and their patient journeys.


  • Tarek Alhamad, MD, MBA, MSPH | Director, Transplant Nephrology, Washington University in St. Louis

Monday, June 3

9:15 AM - 9:45 AM | Product Theater A | Novartis US Medical Affairs

Unraveling the Role of the Complement System in Kidney Disease

A non-CME, disease state presentation highlighting the role of the complement system in kidney disease.


  • Anirban Bose, MD
  • Srini Srinivas, MD, MBA, FAST
  • Meredith Marinaro, PhD